BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8033052)

  • 1. Histopathologic grading of nodular sclerosis Hodgkin's disease. Lack of prognostic significance in 254 surgically staged patients.
    Hess JL; Bodis S; Pinkus G; Silver B; Mauch P
    Cancer; 1994 Jul; 74(2):708-14. PubMed ID: 8033052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
    Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy in clinical stage I and II Hodgkin's disease. The Princess Margaret Hospital Lymphoma Group.
    Gospodarowicz MK; Sutcliffe SB; Bergsagel DE; Chua T
    Eur J Cancer; 1992; 28A(11):1841-6. PubMed ID: 1389522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92.
    van Spronsen DJ; Vrints LW; Hofstra G; Crommelin MA; Coebergh JW; Breed WP
    Br J Haematol; 1997 Feb; 96(2):322-7. PubMed ID: 9029020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.
    Mauch PM; Canellos GP; Shulman LN; Silver B; Tarbell NJ; Come S; Rabin MS; Coleman CN
    J Clin Oncol; 1995 Apr; 13(4):947-52. PubMed ID: 7707123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.
    Mauch P; Tarbell N; Weinstein H; Silver B; Goffman T; Osteen R; Zajac A; Coleman CN; Canellos G; Rosenthal D
    J Clin Oncol; 1988 Oct; 6(10):1576-83. PubMed ID: 3171625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
    Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.
    Shankar AG; Ashley S; Radford M; Barrett A; Wright D; Pinkerton CR
    J Clin Oncol; 1997 Jul; 15(7):2622-30. PubMed ID: 9215833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grades of nodular sclerosis (NSI-NSII) in Hodgkin's disease. Are they of independent prognostic value?
    Wijlhuizen TJ; Vrints LW; Jairam R; Breed WP; Wijnen JT; Bosch LJ; Crommelin MA; van Dam FE; de Koning J; Verhagen-Teulings M
    Cancer; 1989 Mar; 63(6):1150-3. PubMed ID: 2917317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease and non-Hodgkin's lymphoma containing Reed-Sternberg-like giant cells in Taiwan. A clinicopathologic analysis of 50 cases.
    Hong RL; Su IJ; Chen YC; Hsieh HC; Wang CH; Liu CH; Shen MC
    Cancer; 1992 Mar; 69(5):1254-8. PubMed ID: 1739924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of histologic subdivision of Hodgkin's disease nodular sclerosis.
    Cionini L; Arganini L; Mungai V; Biti GP; Bondi R
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(1):65-73. PubMed ID: 696402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparotomy-staged IA versus IIA Hodgkin's disease. A comparative study with evaluation of prognostic factors for stage IIA disease.
    Zagars G; Rubin P
    Cancer; 1985 Aug; 56(4):864-73. PubMed ID: 4016677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients.
    MacLennan KA; Bennett MH; Tu A; Hudson BV; Easterling MJ; Hudson GV; Jelliffe AM
    Cancer; 1989 Oct; 64(8):1686-93. PubMed ID: 2790683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. Australasian Radiation Oncology Lymphoma Group.
    Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Liew KH; Morgan G
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):227-36. PubMed ID: 7836074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages.
    von Wasielewski S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A; von Wasielewski R
    Blood; 2003 May; 101(10):4063-9. PubMed ID: 12543871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.
    Masih AS; Weisenburger DD; Vose JM; Bast MA; Armitage JO
    Cancer; 1992 Jan; 69(1):228-32. PubMed ID: 1727667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.